The FDA will be forced, reluctantly, to approve Brilacidin if deemed safe and effective with use outside the US. That’s a far more likely scenario than approval within our borders. I believe the Beamed investment will give us the needed time and money to ride out the many obstructions to get to commercialization.
Selfishly I hope things improve soon. I am just finishing treatment for cancer and the bills are rolling in. I’m embarrassed to admit how long I’ve been w this company.
News 
Market Data 
Discover 
